A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(21 sites)

China

Beijing Tsinghua Changgung Hospital, Beijing

Peking university first hospital, Beijing

The Second Norman Bethune Hospital of Jilin University, Changchun

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou

Zhujiang Hospital of Southern Medical University, Guangzhou

Sir Run Run Shaw Hospital , affiliated with the Zhejiang University School of Medicine, Hangzhou

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

Shandong Provincial Hospital, Jinan

The First Affiliated Hospital of Guangxi Medical University, Nanning

Affiliated Hospital of Nantong University, Nantong

The Affiliated Hospital of Qingdao University, Qingdao

Northern Theater Command General Hospital, Shenyang

Shengjing Hospital affiliated to China Medical University, Shenyang

Peking University Shenzhen Hospital, Shenzhen

Renmin Hospital of Wuhan University, Wuhan

Wuxi People's Hospital, Wuxi

Xi'an Daxing Hospital, Xi'an

The Second Affiliated Hospital of Xingtai Medical college, Xingtai

Northern Jiangsu People's Hospital, Yangzhou

Yantai Yuhuangding Hospital, Yantai

The First People's Hospital of Zigong, Zigong